Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication Sort descending | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
<197> SPECTROSCOPIC IDENTIFICATION TESTS | NEAR-INFRARED AND RAMAN SPECTROSCOPY | USPNF 2021 ISSUE 1 | Online | 27-Aug-2021 | 1-Sep-2021 | NA | NA | Change (see Near-Infrared Spectroscopy—Theory and Practice 〈1856〉), to: (see 〈856〉), AND Change (see Chemometrics 〈1039〉, Near-Infrared Spectroscopy—Theory and Practice 〈1856〉, and Raman Spectroscopy—Theory and Practice… Read More |
PRAZOSIN HYDROCHLORIDE COMPOUNDED ORAL SUSPENSION | ASSAY/Procedure | Second Supplement to USP41–NF36 | 8945 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In the Mobile phase: Change tetramethylammonium hydrochloride to: tetramethylammonium hydroxide |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In USP Econazole Related Compound B RS: Change Econazole amine; 2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine. C15H14Cl3NO 330.64 to: Econazole amine; 2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)… Read More |
<561> ARTICLES OF BOTANICAL ORIGIN | TEST FOR AFLATOXINS/Method I | USP42–NF37 | 6701 | 31-May-2019 | 1-Jun-2019 | NA | NA | In Aflatoxin standard solution: Change ε = molecular absorptivity to: ε = molar absorptivity AND in paragraph 2 of Aflatoxin standard solution: Change transfer an accurate volume of each aflatoxin standard stock solution to:… Read More |
POWDERED FORSKOHLII | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
<1229.2> STEAM STERILIZATION OF AQUEOUS LIQUIDS | BIOBURDEN/BIOLOGICAL INDICATOR METHOD/Routine Process Control | USP42–NF37 | 8082 | 25-Oct-2019 | 1-Nov-2019 | NA | NA | In the first paragraph: Change calibrartion to: calibration |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | COMPOSITION/Procedure 4: Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin AND In Analysis: Change (3R,3′S … Read More |
OIL- AND WATER-SOLUBLE VITAMINS WITH MINERALS TABLETS | STRENGTH | USP43–NF38 | 5476 | 24-Apr-2020 | 1-May-2020 | NA | NA | In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete , calcium pantothenate (C18H32CaN2O10), and folic acid (C19… Read More |
RISEDRONATE SODIUM DELAYED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Buffer stage/Analysis: Change Calculate the percentage of the labeled amount of risedronate sodium (C7H10NNaO7P7) dissolved: to: Calculate the percentage of the labeled amount of risedronate… Read More |
CLOMIPHENE CITRATE | IDENTIFICATION/B. | USP43–NF38 | 1088 | 25-Sep-2020 | 1-Oct-2020 | NA | NA | Change Spectroscopic Identification Tests 〈197〉, Ultraviolet Spectroscopy: 197U to: Spectroscopic Identification Tests 〈197〉, Ultraviolet-Visible Spectroscopy: 197U |
Strychnine Sulfate | REAGENTS AND REFERENCE TABLES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Reagent Specifications: Change CAS RN®: 60-41-3. to: CAS RN®: 60491-10-3. |
DOBUTAMINE IN DEXTROSE INJECTION | ASSAY/Procedure 1: Dextrose | USP43–NF38 | 1470 | 18-Dec-2020 | 1-Jan-2021 | NA | NA | In Analysis: Change Result = [(100 × a) × (l/α)] × (1/CU) × (Mr1/Mr2) × 100 to: Result = [(100 × a)/(l × α)] × (1/CU) × (Mr1… Read More |
METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution <711> | Revision Bulletin (Official March 01, 2021) | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In Test 14/Analysis: Delete Result4 = {(C4 × V) + [(C3 + C2 + C1) × VS]} × (1/L) × 100 |
ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES | PERFORMANCE TESTS/Dissolution <11>/Test 3/Buffer stage | Revision Bulletin (Official March 01, 2018) | Online | 28-Dec-2018 | 1-Jan-2019 | NA | NA | In the Standard solution: Change 0.25 M sodium hydroxide, to: 0.25 N sodium hydroxide, AND In the Sample solution: Change 0.25sodium hydroxide, to: 0.25 N sodium hydroxide, |
ELEUTHERO ROOT AND RHIZOME POWDER | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change USP Eleutheroside B RS β-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl. C17H24O9 372.37 USP Eleutheroside E RS β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-… Read More |
<1160> PHARMACEUTICAL CALCULATIONS IN PHARMACY PRACTICE | 10. ALLIGATION ALTERNATE AND ALGEBRA METHODS FOR COMBINING MULTIPLE STRENGTHS OF THE SAME ACTIVE PHARMACEUTICAL INGREDIENT | USP42–NF37 | 7831 | 26-Apr-2019 | 1-May-2019 | NA | NA | In 10.2 Algebra Method/10.2.1 Calculating by using the algebra method/Examples—Algebra method: In example 2, in equations 1, 2, 3, and 4 in all instances: Change Cs to: Qs AND In example… Read More |
AZITHROMYCIN FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Azithromycin Related Compound F RS: Change 762.97 to: 762.98 AND In USP Desosaminylazithromycin RS: Change 590.79 to: 590.80 |
<41> BALANCES | REPEATABILITY | First Supplement to USP42–NF37 | 9011 | 26-Jul-2019 | 1-Aug-2019 | NA | NA | In all instances in paragraph 2: Change sr to: s AND In paragraph 2: Change is found to be 0.0015, then Mmin must be ≥ 0.3000 g or 300 mg. to: is found to be 0.00015, then Mmin… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | IMPURITIES/Organic Impurities | USPNF 2022 Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
REPOSITORY CORTICOTROPIN INJECTION | ADDITIONAL REQUIREMENTS | USP43–NF38 | 1174 | 24-Apr-2020 | 1-May-2020 | NA | NA | In USP Reference Standards <11>: Add USP Ascorbic Acid RS |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | IMPURITIES/Limit of 2-Methylbenzhydrol | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Standard solution: Change 7.5 µg/mL of USP 2-Methylbenzhydrol RS in methanol to: 7.5 µg/mL of USP Methylbenzhydrol RS in methanol AND In Analysis: Change CS = concentration of USP 2-Methylbenzhydrol RS in the… Read More |
AMLODIPINE AND ATORVASTATIN TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official November 27, 2019) | Online | 26-Jun-2020 | 1-Jul-2020 | NA | NA | In USP Atorvastatin Related Compound B RS: Change (3S,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt. to: Calcium (3S,5R)-7-[2-(4-… Read More |
ZIPRASIDONE CAPSULES | PERFORMANCE TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Dissolution 〈711〉/Test 1/Tier 1/Phosphate buffer, pH 7.5: Change sodium hydroxide to: sodium hydroxide solution AND In Dissolution 〈711〉/Test 1/Tier 1/Analysis: Change 449.40 to… Read More |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS | ASSAY/Procedure | First Supplement to USP43–NF38 | Online | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In Buffer A: Change monobasic potassium phosphate to: monobasic sodium phosphate |
<661.1> PLASTIC MATERIALS OF CONSTRUCTION | POLYAMIDE 6 | First Supplement to USP43–NF38 | Online | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In Related Substances/Chromatographic system/Column: Change 0.25-mm × 0.25-µm; phase G25 to: 30-m × 0.25-mm; 0.25-µm phase G25 |
OIL- AND WATER-SOLUBLE VITAMINS WITH MINERALS CHEWABLE GELS | STRENGTH | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | In Vitamins B3 (as Niacinamide), B6, and Folic Acid, Method 1/System suitability: Change [Note—The relative retention times for niacinamide, pyridoxine, and folic acid are about 1.0, 1.6, 2.0, and 3.0 respectively.] to: [Note—The relative… Read More |
SACCHARIN | SPECIFIC TESTS/Readily Carbonizable Substances Test <271> | USPNF 2021 ISSUE 1 | Online | 24-Sep-2021 | 1-Oct-2021 | NA | NA | In Matching fluid A: Change Cobaltous chloride CS, ferric chloride TS, cupric sulfate CS, and water (0.1:0.4:0.1:4.4) to: Cobaltous chloride CS, ferric chloride CS, cupric sulfate CS, and water (0.1:0.4:0.1:4.4) |
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | ASSAY/Procedure/Chromatographic system | First Supplement to USP42–NF37 | Online | 26-Apr-2019 | 1-May-2019 | NA | NA | In Column: Change 4.6-mm × 15-cm; 5-µm packing L7. [Note—Conditioning of the Column with Solution A and Solution B ▲(90:10)▲ (ERR 1-Mar-2019) for about 30 min is recommended prior to use.] to: 4.6-mm × 15-cm… Read More |
ACYCLOVIR FOR INJECTION | IMPURITIES/Procedure | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Standard solution A: Change 0.5 μg/mL of Acyclovir standard solution in Solution A to: 0.5 μg/mL of USP Acyclovir RS from Acyclovir standard solution in Solution A AND In Standard solution B:… Read More |
SAW PALMETTO EXTRACT | COMPOSITION/Content of Long-Chain Alcohols and Sterols | USP42–NF37 | 5196 | 28-Jun-2019 | 1-Jul-2019 | NA | NA | In System suitability stock solution B: Change 2 mg/mL each of campesterol, stigmasterol, and USP β-Sitosterol RS and 0.37 mg/mL of stigmastanol to: 0.37 mg/mL of stigmastanol and 2 mg/mL each of campesterol, stigmasterol, and USP β-Sitosterol RS in… Read More |
0.1 N Potassium Permanganate VS | STANDARDIZATION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Standardization with potentiometric endpoint: Change N = g Na2C2O4/mL KMNnO4 solution × 0.06700 to: N = g Na2C2O4/mL KMnO4 solution × 0.06700 |
<1430.5> ANALYTICAL METHODOLOGIES BASED ON SCATTERING PHENOMENA—SMALL ANGLE X-RAY SCATTERING AND SMALL ANGLE NEUTRON SCATTERING | 6. EXPERIMENTAL CONSIDERATIONS | Second Supplement to USP42–NF37 | Online | 22-Nov-2019 | 1-Dec-2019 | NA | NA | In 6.2 Resolution/6.2.1 Size resolution: Change qmin < π/dmax π/dmax to: qmin < π/dmax |
DEXAMETHASONE SODIUM PHOSPHATE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = (rU/rS) × (CS/CU) × (Mr1/Mr22) × 100 to: Result = (rU/r… Read More |
<191> IDENTIFICATION TESTS—GENERAL | CHEMICAL IDENTIFICATION TESTS | USP43–NF38 | 6587 | 24-Apr-2020 | 1-Aug-2020 | NA | NA | In Bicarbonate/B.: Change (1:20) to: (1 in 20) AND In Borate/A.: Change (1:50): to: (1 in 50): AND In Calcium/A.: Change (1:20) to: (1 in 20) AND In Carbonate/B.:… Read More |
PIPERACILLIN | SPECIFIC TESTS | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Sterility Tests 〈71〉: Change Where the label states that Piperacillin is sterile or that it must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements when tested as directed in Test for… Read More |
NICOTINE TRANSDERMAL SYSTEM | PERFORMANCE TESTS/Drug Release <724> | USP43–NF38 | 3153 | 25-Sep-2020 | 1-Oct-2020 | NA | NA | In Tests 1, 2, 4, and 5/Tolerances: Change conform to Dissolution <711>, Acceptance Table 1. to: conform to Acceptance Table 1. |
DICYCLOMINE HYDROCHLORIDE | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In B. Identification Tests—General 〈191〉, Chemical Identification Tests, Chloride: Change Meets the requirements when tested as specified in test B. to: Meets the requirements of the test for amine… Read More |
FENTANYL CITRATE | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 26-Feb-2021 | 1-May-2021 | NA | NA | Change 528.59 to: 528.60 |
MYCOPHENOLATE MOFETIL TABLETS | PERFORMANCE TESTS/Dissolution <711> | USP43–NF38 | 3049 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In Test 3/Analysis: Change Result = (rU/rS) × CS × D rU = peak response from the Sample solution rS = peak response from the… Read More |
SALMETEROL INHALATION POWDER | PERFORMANCE TESTS | First Supplement to USP41–NF36 | Online | 25-Jan-2019 | 1-Feb-2019 | NA | NA | In the definition list in Particle Size Distribution by Cascade Impaction/Analysis: Change Mr1 = molecular weight of salmeterol free base, 415.75 to: Mr1 = molecular weight of salmeterol… Read More |
CARBOPLATIN FOR INJECTION | IMPURITIES/Limit of 1,1-Cyclobutanedicarboxylic Acid | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Chromatographic system/Column: Change 4.0-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 |
DOXORUBICIN HYDROCHLORIDE | ASSAY/Procedure | USP42–NF37 | 1481 | 31-May-2019 | 1-Jun-2019 | NA | NA | In the Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXYCYCLINE HYCLATE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
<1160> PHARMACEUTICAL CALCULATIONS IN PHARMACY PRACTICE | 19. MEAN KINETIC TEMPERATURE | USP42–NF37 | 7831 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In 19.4 Example Calculations of MKT for CRT Storage Evaluation/Example 3—Calculation of Annual MKTStep 3: Change 3.354 to: 3.340 AND In Step 4: Change 2.795 to: 2.783 AND In Step 5:… Read More |
CHLORHEXIDINE GLUCONATE ORAL RINSE | IMPURITIES/Limit of p-Chloroaniline | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: 1.0 µg/mL of USP p-Chloroaniline RS in Diluent to: Standard solution: 0.001 mg/mL of USP p-Chloroaniline RS in Diluent AND In Analysis: Change Result = (rU… Read More |
MENADIONE | ASSAY/Procedure | USP43–NF38 | 2780 | 24-Apr-2020 | 1-May-2020 | NA | NA | In Endpoint detection: Change Potentiometric to: Visual |
POLYETHYLENE GLYCOL 12 CETOSTEARYL ETHER | IDENTIFICATION | USPNF Online | Online | 28-Apr-2023 | 1-Aug-2023 | NA | NA | Change: B. Test for Hydroxyl Group: to: B. Hydroxyl Value: AND In D./Analysis: Change Dissolve or disperse the Sample in alcohol. to: Dissolve or disperse the … Read More |
<1125> NUCLEIC ACID-BASED TECHNIQUES—GENERAL | APPENDICES/Appendix 1 | USP43–NF38 | 7865 | 31-Jul-2020 | 1-Aug-2020 | NA | NA | In footnote 1: Change http://ts.nist.gov/measurementservices/referencematerials/index.cfm. to: https://www.nist.gov/srm. |
METHYLBENZETHONIUM CHLORIDE | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/Analysis: Change Calculate the percentage of methylbenzethonium chloride (C28H44ClNO2 · H2O) in the portion of Methylbenzethonium Chloride taken: to: Calculate the percentage of… Read More |
DAPSONE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Dissolution 〈711〉/Standard solution: Change USP Dapsone RS of a known concentration in Medium to: (L/1000) mg/mL of USP Dapsone RS in Medium, where L is the label claim in mg/Tablet. Transfer a portion of this… Read More |